NCT07004335
- Conditions
- Advanced Melanoma, Bevacizumab, CTLA-4, +4 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Shijiazhuang, China
Clinical trial condition
Bevacizumab
Explore clinical trials studying Bevacizumab. Study availability and eligibility vary by location and protocol.
17 public trials
8 recruiting studies
Bevacizumab trial results
Not Yet Recruiting
Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
NCT06539559
- Conditions
- Bevacizumab, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Beijing Chaoyang District San Huan Cancer Hospital Beijing, Beijing Municipality, China
- Cancer Hospital of HuanXing ChaoYang District Beijing, Beijing Municipality, China
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT05263947
- Conditions
- Bevacizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT01951482
- Conditions
- Bevacizumab, Brain Diseases, Brain Metastases, +8 more
- Locations
-
- Sun Yat-sen University of Cancer Center Guangzhou, Guangdong, China
NCT05807893
- Conditions
- Bevacizumab, Brain Diseases, Brain Metastases, +17 more
- Locations
-
- Likun Chen Guangzhou, Guangdong, China
NCT01810744
- Conditions
- Astrocytoma, Bevacizumab, Capillaroscopy, +20 more
- Locations
-
- Centre Georges François Leclerc Dijon, France
NCT01311960
- Conditions
- Anti-VEGF, Bevacizumab, Conjunctival Diseases, +3 more
- Locations
-
- Faculty of medicine, Chulalongkorn university Pathumwan, Bangkok, Thailand